Company Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.
The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
| Country | United States |
| Founded | 2003 |
| IPO Date | Jun 28, 2018 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 203 |
| CEO | Keith Sullivan |
Contact Details
Address: 3222 Phoenixville Pike Malvern, Pennsylvania 19355 United States | |
| Phone | 610 640 4202 |
| Website | neurostar.com |
Stock Details
| Ticker Symbol | STIM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001227636 |
| CUSIP Number | 64131A105 |
| ISIN Number | US64131A1051 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Keith J. Sullivan | President, Chief Executive Officer and Director |
| Stephen J. Furlong M.S. | Executive Vice President, Chief Financial Officer and Treasurer |
| Rusty Page | Senior Vice President of Operations and Quality |
| Lisa Metzner-Rosas | Senior Vice President and Chief Marketing Officer |
| Sara Grubbs | Senior Vice President and Chief Revenue Officer |
| Rick Grubbs | Senior Vice President of National Accounts |
| Cory S. Anderson | Senior Vice President of Research & Development and Clinical |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 17, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Dec 10, 2024 | 8-K | Current Report |
| Nov 14, 2024 | SCHEDULE 13G | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SCHEDULE 13G/A | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 13, 2024 | 8-K/A | [Amend] Current report |
| Nov 13, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |